Catherine M Bollard

18PUBLICATIONS
115CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 22, 2026
Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

|Jul 01, 2026
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

|May 15, 2025
Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study.

Danielle K Sohai, Michael D Keller, Patrick J Hanley

|Aug 19, 2024
Applications of cell therapy in the treatment of virus-associated cancers.

Keri Toner, Chase D McCann, Catherine M Bollard

|Jun 17, 2024
Enhancing pediatric access to cell and gene therapies.

Crystal L Mackall, Catherine M Bollard, Nancy Goodman

|Apr 18, 2024
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.

Michael D Keller, Patrick J Hanley, Yueh-Yun Chi

Pageof 3

Frequent Collaborators

4 joint publications

Michael D Keller

4 joint publications

Conrad Russell Y Cruz

4 joint publications

Patrick J Hanley

3 joint publications

Christopher Lazarski